FindTrial
Sign In

DAA effect on DNA Telomere in Hepatitis C virus related Cirrhosis

Impact of DAAs on Leucocytic DNA Telomere Length in HCV Related Hepatic Cirrhosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201804003186772
Enrollment
Unknown
Registered
2018-03-12
Start date
2016-10-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Hepatitis C virus related hepatic cirrhosis

Interventions

Direct Antiviral Therapy
contols: received no therapy and were HCV negative and healthy

Sponsors

Alexandria Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hepatitis C virus related cirrhosis naive

Exclusion criteria

Exclusion criteria: concomitant Hepatitis B malignancy pregnancy renal failure

Design outcomes

Primary

MeasureTime frame
cure of experimental group receiving therapy—

Secondary

MeasureTime frame
effect on DNA telomere—

Countries

Egypt

Contacts

Public ContactEmad Arida

alexandria faculty of medicine

aridae@yahoo.com+201223129135

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026